Clinical Trial Search

Primary: Evaluation of Acceptability of Intervention as Measured by Acceptability Questionnaire — 4.47 score on a scale

Primary: Number of Index Participants and Their Household Contacts With SARS-CoV-2 RNA Detection in Nasal Samples Over the Study/Surveillance Period — 98.9; 99.2; 99.1; 98.0…

Primary: SARS-CoV-2 Infection — 4; 2 Participants

Primary: Difference in Days Alive and Out of Hospital — 29.5; 29.4 days

Primary: PTSD Symptom Severity — 16.36; 17.10; 15.56; 15.78 score on a scale — p=.77

Primary: Main Reason for Testing for COVID-19 — 1632; 493; 238; 343 Participants

Primary: Number and Severity of Confirmed COVID-19 Infections Among Cancer Centre Staff and Patients at 12 Months — 55; 36 Participants

Primary: Sensitivity of Detecting SARS-CoV-2 RNA — 31; 0 Participants

Primary: Positive Percent Agreement — 53; 2 Participants

Primary: Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation — 155 Participants

Primary: Help Seeking Intention — 7.4; 7.9; 7.3; 8.2 units on a scale — p=0.031

Primary: The Incidence of COVID-2019 Cases. — 259.95 COVID-2019 cases per 1000 person

Primary: 30 Candidate Ag Test Self-collections — 53; 0 Participants

Primary: Completion of COVID-19 Test — 72; 60 Participants

Primary: Number of Samples Tested — 3692 samples

Primary: Participants Enrolled — 36 Participants

Primary: Instrumental Activities of Daily Living and Activities of Daily Living (I/ADL) Score — 3.40; 3.05; 3.50; 3.40 I/ADL Score — p=0.77

Primary: Number of Composite Primary End Point (Critical Care Admission, Palliative Discharge When Discharged From Hospital, or Mortality Within the 6 Weeks After Diagnosis of…

Primary: Measure of Daily Stool Frequency for Patients With COVID Treated With Bismuth — 3 bowel movements

Primary: Brief Psychiatric Rating Scale (BPRS) — 29.30; 32.80; 30.25 score on a scale

Primary: Proportion of Eligible Participants Who Agree to Participate — 74 Participants

Primary: Testing Barriers and Hesitancy — 0.29; 0.24 score on a scale — p=0.09

Primary: Number of Participants With National Early Warning Score (NEWS) Change From 3 to 0 — 44; 29 Participants

Primary: Number of Participants With Symptomatic COVID-19 at 60 Days — 24; 19 Participants — p=0.52

Primary: Perceived Stress Scale — -3.2 units on a scale

Primary: Number of Symptomatic SARS-CoV-2 Infections Between Randomized, Study-vaccinated Participants and the Comparator Group — 48; 94 Participants

Primary: The Percent of Participants With Tracheal Intubation or Death Prior to Tracheal Intubation — 26.2; 22.2 percentage of participants

Primary: Percentage of Patients at Each Sample Timepoint With a Positive Detection of Immunoglobulin G (IgG) Specific Antibodies to SARS-CoV-2 (Spike-protein). — 34.9; 38.3…

Primary: Number of Patients With TEAEs — 3; 4; 3; 1 Participants

Primary: Motor Balance as Measured by Timed Up and Go (TUG) — 20.57 seconds